Further, systemic administration of TNFα coupled to ACDCRGDCFCG-peptide, a ligand for αVβ3-integrin, has enabled targeting the tumor vasculature and inducing anti-tumor effects in tumor-bearing mice (304). The gene discussed is TNF; the disease is neoplasm.